Categories: Business

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) – Artificial intelligence has sped up early-stage drug development work at some of the world's largest

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

BRIEF-HG Gets Sales Commitments For Over 85% Of Jacktel Shares

Nov 20 (Reuters) - Hunter Group ASA: * UPDATE ON RECOMMENDED CASH PURCHASE ORDER FOR…

1 minute ago

Saliba fit for Arsenal's Newcastle trip, Zubimendi out with injured hamstring

VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM ARSENAL'S MANAGER MIKEL ARTETA AHEAD OF FACING NEWCASTLE UNITED…

5 minutes ago

BRIEF-Ground Rents Income Fund Says It Is Reviewing Detail Of Commonhold And Leasehold Reform Bill

Nov 20 (Reuters) - Ground Rents Income Fund PLC : * GROUND RENTS INCOME FUND:…

5 minutes ago

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial…

8 minutes ago

Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines

By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial…

9 minutes ago

Spain's government approves new rules for data centres

MADRID, Nov 20 (Reuters) - The Spanish government on Friday approved new water, energy and…

13 minutes ago